Two-year outcome of half-time photodynamic therapy for chronic central serous chorioretinopathy with and without choroidal neovascularization.

Aya KamimuraAkiko MikiMaya KishiMina OkudaMayuka Hayashida-HiranoMari SakamotoWataru MatsumiyaHisanori ImaiSentaro KusuharaMakoto Nakamura

Published in: PloS one (2023)

A htPDT for cCSC was less effective in eyes with CNV than in those without CNV regarding the recurrence and persistence of SRF. Additional treatment might be required in eyes with CNV during 24-month follow-up periods.

Keyphrases

optical coherence tomography
photodynamic therapy
diabetic retinopathy
high grade
fluorescence imaging
vascular endothelial growth factor
combination therapy